Estradiol Completed Phase 2 Trials for Schizophrenic Disorders / Schizophreniform Disorder / Schizoaffective Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00206570Clinical Estradiol Trial in Women With Schizophrenia
NCT00206557The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study